Related Experiment Videos
[Clinical experience with ambroxol syrup (author's transl)].
Arzneimittel-Forschung
|January 1, 1978
Summary
Ambroxol syrup effectively reduced coughing and dyspnea in patients with acute and chronic bronchitis. This mucolytic agent demonstrated significant improvements in expectoration with no observed side effects.
Area of Science:
- Pharmacology
- Respiratory Medicine
Context:
- Investigating the efficacy of ambroxol hydrochloride (NA 872) in non-hospitalized patients.
- Focusing on treatment for acute and chronic bronchitis.
Purpose:
- To evaluate the therapeutic effects of ambroxol syrup on bronchitis symptoms.
- To assess the onset, duration, and side effect profile of ambroxol treatment.
Summary:
- Open trial involving ambroxol syrup for acute and chronic bronchitis.
- Observed marked reduction in coughing and dyspnea.
- Noted improvement in expectoration, with maximum effect by day three.
- Sustained therapeutic effect with prolonged treatment; no side effects reported.
Impact:
- Demonstrates ambroxol's potential as a safe and effective treatment for bronchitis.
- Highlights the rapid onset and sustained efficacy of ambroxol.
- Provides evidence for ambroxol's role in managing respiratory symptoms.